dentalcorp (DNTL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Operates 575 dental practices across Canada, serving 2.4M active patients with 5.6M annual visits as of June 30, 2025, and is the largest national dental network.
Focuses on highly recurring, essential dental services insulated from economic cycles, with 92% recurring patient visits and over 90% of revenue from routine care.
Demonstrated double-digit growth in key financial metrics since IPO in 2021, with record Adjusted EBITDA and margin expansion year-over-year.
Robust technology stack, including AI diagnostics and centralized systems, drives efficiency and patient care.
Treated over 125,000 patients under the Canadian Dental Care Plan, with 95% of practices participating.
Financial highlights
Q2 2025 revenue was $435.2M, up 8.9% year-over-year; Adjusted EBITDA was $81.2M, up 9.9% year-over-year; Adjusted EBITDA margin improved by 20 basis points to 18.7%.
Adjusted Free Cash Flow for Q2 2025 was $45.6M ($0.23/share), up 12% year-over-year.
Last 12 months' pro forma revenue reached $1.7B, with $314M pro forma adjusted EBITDA and $165M adjusted free cash flow.
Net income (loss) for the last 12 months was ($45M); cash flow from operating activities was $220M.
Practice-level EBITDA after rent margin exceeds 22%; average revenue per practice is $2.9M.
Outlook and guidance
Reaffirmed full-year 2025 guidance: 3%-5% same practice revenue growth, 20 basis point improvement in adjusted EBITDA margin, and $25M+ pro forma adjusted EBITDA from acquisitions.
Q3 2025 revenue expected to increase 10%-12% year-over-year, with 3%-5% same practice revenue growth and 20 basis point margin expansion.
Net Debt / PF Adjusted EBITDA after rent ratio targeted at 3.0x medium-term.
15%+ pre-tax Adjusted Free Cash Flow per Share growth targeted for 2025.
Acquisitive pacing expected in the $25M-$30M range for 2025.
Latest events from dentalcorp
- Arrangement to acquire all shares for CAD 11 each approved, pending court and closing conditions.DNTL
AGM 20253 Feb 2026 - Q2 revenue and EBITDA grew double digits, with CDCP boosting patient volumes and outlook strong.DNTL
Q2 20242 Feb 2026 - Strong M&A-driven growth, high recurring revenue, and positive outlook define the Canadian dental sector.DNTL
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Double-digit growth, margin expansion, and strong cash flow conversion in Q3 2024.DNTL
Q3 202415 Jan 2026 - 2024 revenue up 8.4% to $1.55B, margin at 18.5%, and 2025 outlook strong.DNTL
Q4 202425 Dec 2025 - Q1 2025 saw double-digit EBITDA growth, margin expansion, and record free cash flow.DNTL
Q1 202521 Nov 2025 - Double-digit growth, margin expansion, and AI innovation drive leadership in Canadian dentistry.DNTL
Stifel Jaws & Paws Conference 202521 Nov 2025 - Revenue and EBITDA rose double digits; company to be acquired by GTCR at a 33% premium.DNTL
Q3 20256 Nov 2025